Pharmagreen Biotech Inc. PHBI
Pharmagreen Biotech Inc. statistics & valuation
Market cap$622,211
Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Return on assets | -419.0% | -1214.8% | -932.5% | -121.8% | -238.9% |
| Return on equity | 48.0% | 267.8% | 84.6% | 92.0% | 77.4% |
| Debt / equity | — | — | -0.01× | — | — |
| Current ratio | 0.11 | — | 0.08 | 0.13 | 0.11 |
Computed from company filings · US · as of 2022-09-30. Facts plus Stocktoria's own computed scores — not investment advice.